Top 10 Books about Stock Investing to read in 2018. Read more.

IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

IMGN - ImmunoGen

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#593()/6711

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE 3.04%
PRICE $11.19
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Request Prediction
0.00%
Predict

ImmunoGen Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 4.55% ( 2018-01-31 )
Cash 738.9 mill
Loans n/a
Beta 2.16
ROA -33.91
Buy candidate since 2018-02-09 Gain 25.45%

ImmunoGen gained 3.04% in the last trading day, rising from $10.86 to $11.19 The price has risen in 7 of the last 10 days and is up by 27.74% over the past 2 weeks. Volume fell in the last day by -1.52 million shares, and in total, 2.63 million shares bought and sold for approximately $29.48 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Access today's Top 5 Buy Candidates

Trend

ImmunoGen lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 80.21% during the next 3 months and, with 90% probability hold a price between $17.44 and $21.36 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. ImmunoGen holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $11.01 and $8.90. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday February 22, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 59 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $10.55 and $9.18. On the upside the stock meets some resistance just above today's level from accumulated volume at $11.25, $11.27 and $11.68.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmunoGen finds support just below today's level at $10.55. If this is broken, then the next support from accumulated volume will be at $9.18 and $8.56. The stock is about to test the resistance from accumulated volume at $11.25 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $10.55 Price: $11.19 Resistance: $11.25

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.63 between high and low, or 5.87%. For the last week, the stock has had a daily average volatility of 9.20%.

Our recommended stoploss: $10.58 (-5.49%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Trade IMGN CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL